Exact Mass: 306.0441
Exact Mass Matches: 306.0441
Found 90 metabolites which its exact mass value is equals to given mass value 306.0441,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate
2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.
Kinobscurinone
An organic heterotetracyclic compound that is 10,11-dihydro-5H-benzo[b]fluorene substituted by a methyl group at position 1, hydroxy groups at positions 4 and 9, and oxo groups at positions 5, 10 and 11.
Vadadustat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate
3,5-Dihydroxy-1H,3H-2-benzopyrano[6,5,4-mna]xanthene-1-one
3,4-dihydroxy-5-phenyl-naphthalene-1,8-dicarboxylic acid anhydride|3,4-Dihydroxy-5-phenylnaphthalsaeureanhydrid|5,6-Dihydroxy-7-phenyl-1H,3H-naphtho[1,8-cd]pyran-1,3-dione|5,6-dihydroxy-7-phenyl-3H-benzo[de]isochromene-1,3-dione
Methyl brevifolincarboxylate
Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.
6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C
5-((E)-2-Oxo-benzofuran-3-yliden)-3-phenyl-furan-2,4-dion|5-((E)-2-oxo-benzofuran-3-ylidene)-3-phenyl-furan-2,4-dione
7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one
6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]
2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)
Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate
4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile
5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE
3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate
3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione
6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine
5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid
3-[(2Z)-3-Hydroxy-4-phenyl-5-oxofuran-2(5H)-ylidene]benzofuran-2(3H)-one
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate
N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide
2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid
(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid
4-(5-O-phospho-beta-D-ribofuranosyl)phenol
A ribose monophosphate that is D-ribofuranose 5-phosphate in which the anomeric OH group is replaced by a 4-hydroxy phenyl group (the beta-D-anomer).
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.
